Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients

NCT00121784 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Poor recruitment

Conditions

Heart Transplantation

Interventions

DRUG: mycophenolate mofetil [CellCept]

Sponsor

Hoffmann-La Roche